Generon (Shanghai) Corporation Ltd.

BINEUTA

pharmaceuticals used for stimulating white blood cell production; pharmaceuticals for the treatment of stroke, spinal injury, neurological disorders and neurodegenerative diseases;

ITAB

pharmaceuticals, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, B-cell disorders, and minimal residual diseases, in the form of intravenous, sub-cutaneous, intraperitoneal, intra-muscular and aerosol therapies;